» Articles » PMID: 34530829

Determination of a Six-gene Prognostic Model for Cervical Cancer Based on WGCNA Combined with LASSO and Cox-PH Analysis

Overview
Publisher Biomed Central
Date 2021 Sep 17
PMID 34530829
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: This study aimed to establish a risk model of hub genes to evaluate the prognosis of patients with cervical cancer.

Methods: Based on TCGA and GTEx databases, the differentially expressed genes (DEGs) were screened and then analyzed using GO and KEGG analyses. The weighted gene co-expression network (WGCNA) was then used to perform modular analysis of DEGs. Univariate Cox regression analysis combined with LASSO and Cox-pH was used to select the prognostic genes. Then, multivariate Cox regression analysis was used to screen the hub genes. The risk model was established based on hub genes and evaluated by risk curve, survival state, Kaplan-Meier curve, and receiver operating characteristic (ROC) curve.

Results: We screened 1265 DEGs between cervical cancer and normal samples, of which 620 were downregulated and 645 were upregulated. GO and KEGG analyses revealed that most of the upregulated genes were related to the metastasis of cancer cells, while the downregulated genes mostly acted on the cell cycle. Then, WGCNA mined six modules (red, blue, green, brown, yellow, and gray), and the brown module with the most DEGs and related to multiple cancers was selected for the follow-up study. Eight genes were identified by univariate Cox regression analysis combined with the LASSO Cox-pH model. Then, six hub genes (SLC25A5, ENO1, ANLN, RIBC2, PTTG1, and MCM5) were screened by multivariate Cox regression analysis, and SLC25A5, ANLN, RIBC2, and PTTG1 could be used as independent prognostic factors. Finally, we determined that the risk model established by the six hub genes was effective and stable.

Conclusions: This study supplies the prognostic value of the risk model and the new promising targets for the cervical cancer treatment, and their biological functions need to be further explored.

Citing Articles

Construction and validation of a prognostic signature using WGCNA-identified key genes in osteosarcoma for treatment evaluation.

Chen Z, Ni R, Hu Y, Yang Y, Chen J, Tian Y Transl Cancer Res. 2025; 14(1):254-271.

PMID: 39974409 PMC: 11833431. DOI: 10.21037/tcr-24-1398.


Comprehensive bioinformatics and machine learning analyses for breast cancer staging using TCGA dataset.

Das S, Tasnim W, Rana H, Acharjee U, Islam M, Khatun R Brief Bioinform. 2024; 26(1).

PMID: 39656775 PMC: 11630003. DOI: 10.1093/bib/bbae628.


Cancer Therapeutic Potential and Prognostic Value of the SLC25 Mitochondrial Carrier Family: A Review.

Gao R, Zhou D, Qiu X, Zhang J, Luo D, Yang X Cancer Control. 2024; 31:10732748241287905.

PMID: 39313442 PMC: 11439189. DOI: 10.1177/10732748241287905.


Identification of ribosome biogenesis genes and subgroups in ischaemic stroke.

Wang X, Zhang X, Liao N, He Z, Chen Q Front Immunol. 2024; 15:1449158.

PMID: 39290696 PMC: 11406505. DOI: 10.3389/fimmu.2024.1449158.


CuPCA: a web server for pan-cancer association analysis of large-scale cuproptosis-related genes.

Xu Y, Ma Z, Wang Y, Zhang L, Ye J, Chen Y Database (Oxford). 2024; 2024.

PMID: 39231258 PMC: 11373563. DOI: 10.1093/database/baae075.


References
1.
Di Y, Chen D, Yu W, Yan L . Bladder cancer stage-associated hub genes revealed by WGCNA co-expression network analysis. Hereditas. 2019; 156:7. PMC: 6350372. DOI: 10.1186/s41065-019-0083-y. View

2.
Kori M, Arga K . Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective. PLoS One. 2018; 13(7):e0200717. PMC: 6051662. DOI: 10.1371/journal.pone.0200717. View

3.
Ji Y, Wang H . Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis. World J Surg Oncol. 2020; 18(1):197. PMC: 7414550. DOI: 10.1186/s12957-020-01974-w. View

4.
Kugler K, Mueller L, Graber A, Dehmer M . Integrative network biology: graph prototyping for co-expression cancer networks. PLoS One. 2011; 6(7):e22843. PMC: 3146497. DOI: 10.1371/journal.pone.0022843. View

5.
He Y, Yu X, Zhang M, Guo W . Pan-cancer analysis of mC regulator genes reveals consistent epigenetic landscape changes in multiple cancers. World J Surg Oncol. 2021; 19(1):224. PMC: 8323224. DOI: 10.1186/s12957-021-02342-y. View